🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in France / NCT06436937
Recruiting Not applicable

Protein Quality of Fava Bean and Honey Chlorella in Humans

NCT06436937 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2024-06-13
Last updated
2025-05-20

Condition(s) studied

Protein Quality of Chlorella and Fababean Meat Analogue

Investigational drug(s) / intervention(s)

Single meal containing 20 g of 15N intrinsically labelled protein from honey chlorellaSingle meal containing 20 g of 15N intrinsically labelled protein from faba bean meat analogue

Single meal containing 20 g of 15N intrinsically labelled protein from honey chlorella: Ingestion of a 15N labeled test meal. Subjects are equipped with a nasoileal tube. 15N is followed in biological fluids (plasma, effluents, urines).

Single meal containing 20 g of 15N intrinsically labelled protein from faba bean meat analogue: Ingestion of a 15N labeled test meal. Subjects are equipped with a nasoileal tube. 15N is followed in biological fluids (plasma, effluents, urines).

Study summary

The goal of the project is to determine the protein quality of alternative protein sources, honey chlorella and Faba bean, ingested as mixed meals in healthy subjects equipped with naso-ileal tube. For this purpose, Chlorella and Faba bean are intrinsically labelled with 15N. Faba bean is processed to produce a meat analogue. Chlorella is introduced in a drink. The protein quality is determined by following the digestive and metabolic fate of 15N during a 8h postprandial investigation.

Eligibility

Sex
ALL
Min age
18 Years
Max age
60 Years
Healthy volunteers
Accepted
Inclusion Criteria: * 18\<BMI\<30 * Good health (WHO=0) * For woman: use of birth control Exclusion Criteria: * food allergy * allergy against latex * pregnant women * Positive serology for AgHBS, AcHbc, HCV, HIV * Anemia * Excessive alcohool consumption * Hypertension, diabetes, digestive, hepatic or renal diseases, cardiac disease * Exercice\>7h/week * Blood donation within 3 months before the study * Participation to another clinical study within 3 months before the study

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Research Center on Volunteers Bobigny France Recruiting

More Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement trials in France

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06436937 on ClinicalTrials.gov ↗ ← All trials in France